Sign in
Taking people in United StatesNo phase

Impact of Vitamin D on Gut Microbiome and Metabolome Among Pediatric Oncology Patients

Key facts

Who runs it
Children's Hospital of Orange County
Where
Orange, United StatesSee the site
Trial code
Status
Recruiting
People taking part
30 people, planned
Started
9 Nov 2026
Expected to end
31 Dec 2027
Type of study
Observational
Record updated
16 November 2026

Who can take part

Age
0 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Ages 0-18 years
  • Newly diagnosed with acute lymphoblastic leukemia, including B-cell ALL, T-cell ALL, mixed phenotype actue leukemia (MPAL), and Philadelphia-positive or Philadelphia-like ALL

Who cannot take part

  • Diagnosed with other malignancies, congenital gastrointestinal or bowel diseases, or inflammatory bowel diseases
  • Hypersensitivity to vitamin D
  • Pregnant

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 0 and 18 years old?

This trial is currently available in United States.

  • Children's Hospital of Orange CountyOrange, United StatesContact: Kathryn Duvall, MSN RN CCRP CPONTaking people

About the trial

What the trial wants to find out

Brief Summary The purpose of this observational study is to better understand how vitamin D levels affect the gut microbiome (the bacteria that live in the intestines) in children who are newly diagnosed with acute lymphoblastic leukemia (ALL). Researchers want to learn whether low vitamin D levels are linked to changes in gut bacteria and whether this may affect how children with ALL respond to chemotherapy.

Read full original descriptionShow less

The main questions this study aims to answer are:

* Are the gut bacteria different in children with ALL who have low vitamin D levels compared to those with normal vitamin D levels at the time of diagnosis? * How do vitamin D levels relate to changes in gut bacteria and related body processes before and after induction chemotherapy? Researchers will compare children who have low vitamin D levels with those who have normal vitamin D levels to see if there are differences in their gut bacteria and how those bacteria change during early treatment. The stool samples will be studied in specialized laboratories to better understand how vitamin D and gut bacteria interact.

The results of this study may help doctors understand whether monitoring and managing vitamin D levels could improve care and treatment outcomes for children with ALL.

Participants will:

Have four study visits:

* Screening: Review and sign consent/assent forms, review of Inclusion/Exclusion Criteria, medical history, and current medications * At diagnosis (baseline): Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection * Day 29-32 - At the end of induction chemotherapy: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment * Day 90-97 after Induction: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07938333, who can take part
Record updated
16 November 2026